Clinical Trials Directory

Trials / Completed

CompletedNCT03757429

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Infection with human respiratory syncytial (RS) virus is the most common cause of hospital stay due to pediatric lower respiratory tract infection. An exaggerated immune response contributes to the pathogenesis and small children may have over reactive airways for a long time after an infection. New research has shown that polymorphonuclear leukocytes (PMNs) are stimulated by the virus. Besides fighting the infection they also cause collateral damage to the host. Among other mechanisms PMNs stimulates mucus formation that affects breathing. They also secrete enzymes, toxic proteins and free radicals that may cause harm to lung tissue and airways. The current project strives towards identifying and quantifying inflammatory mediators in sputum, urine and blood of children with severe RS-virus infection. The ultimate aim of the project is to, in detail, describe proteins contributing to the pathogenesis of the disease.

Conditions

Interventions

TypeNameDescription
OTHERRS-virus infectionThe intervention consists of lower respiratory tract infection due to RS-virus

Timeline

Start date
2018-04-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2018-11-29
Last updated
2022-05-31

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03757429. Inclusion in this directory is not an endorsement.

Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus (NCT03757429) · Clinical Trials Directory